Thermo Fisher Scientific (TMO) - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8835561023

(NYSE:TMO Stock) Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts. Web URL:

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Thermo Fisher Scientific (TMO) - Stock & Dividends

TMO Stock Overview

Market Cap in USD 211,291m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 1978-01-13

TMO Stock Ratings

Fundamental 2.79
Dividend 4.44
Growth 5y 5.85
Rel. Performance vs Sector -1.28
Analysts 4.11
Fair Price Total Ret. 551.69
Fair Price DCF 412.88

TMO Dividends

Yield 12m 0.25%
Yield on Cost 5y 0.56%
Dividends CAGR 5y 13.00%
Payout Consistency 36.2%

TMO Growth Ratios

Growth 12m 1.08%
Growth Correlation 12m -24%
Growth Correlation 3m 76%
CAGR 5y 17.09%
CAGR / Mean Drawdown 1.61
Sharpe Ratio 12m -0.19
Alpha vs SP500 12m -21.48
Beta vs SP500 5y weekly 0.81
CAPM 7.47%
Average Daily Range 2m 2.04%
Regime Oscillator 62.09
Volatility GJR Garch 1y 26.34%
Price / SMA 50 2.7%
Price / SMA 200 6.82%
Current Volume 786.5k
Average Volume 20d 1681.8k

External Links for TMO Stock

Wall Street JournalBenzingaYahoo Finance
X (Twitter)Stocktwits
Fund Manager Positions
What is the price of TMO stocks?
As of February 22, 2024, the stock is trading at USD 552.85 with a total of 786,477 shares traded.
Over the past week, the price has changed by +0.84%, over one month by -0.10%, over three months by +14.68% and over the past year by +0.65%.
Why is TMO stock down?
Check with which Index or Commodity TMO has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return TMO Return S&P 500
1 Month -0.10% 2.85%
3 Months 14.68% 10.14%
12 Months 0.65% 26.48%
What is the forecast for TMO stock price target?
According to ValueRays Forecast Model, TMO Thermo Fisher Scientific will be worth about 595.8 in February 2025. The stock is currently trading at 552.85. This means that the stock has a potential upside of +7.77%.
Issuer Forecast Upside
Wallstreet Target Price 593.2 7.3%
Analysts Target Price 601.9 8.9%
ValueRay Target Price 595.8 7.8%